BREIL GL10 Manual do Utilizador descarregar pdf (Página 33)

I A61K038/55, A 61 K 031/18,

A61K031/40, A 61 K 031/495,

C07C311/14, C 07 C 311/19,

C07D209/10, C 07 D 405/12

A 00 771 565

B 96116994.3

C 23.10.1996 Q En

H 07.05.1997 R En

E 02.01.2003

F 25.10.1995 JP 27748595

19.09.1996 JP 24804696

K Angiogense-Inhibitor

O Senju Pharmaceutical Co., Ltd.

5-8, Hiranomachi 2-chome, Chuo-Ku

Osaka-shi, Osaka 541-0046 (JP)

N Fukiage, Chiho

17-24 Kisabe 2-chome

Katano-shi, Osaka 576 (JP)

Inoue, Jun 603, Rui-Shatore Suma

Myodani

1-6 Shirakawa-azafukei

Suma-ku, Kobe-shi, Hyogo 654.01

(JP)

Nakamura, Masayuki

112, kamo, Shikama-ku

Himeji-shi, Hyogo 670 (JP)

Yoshida, Yuka

634-141 Wada-cho

Nishiwaki-shi, Hyogo 677 (JP)

Azuma, Mitsuyoshi

4-13-102, Manchidani-cho

Nishinomiya-shi, Hyogo 662 (JP)

I A 61 K 038/55 Z C 07 C 311/19

A 00 928 786

I A61K038/57, A 61 P 029/00

A 00 817 646

B 96909862.3

C 26.03.1996 Q En

H 14.01.1998 R En

E 08.01.2003

F 27.03.1995 US 411043

K VERFAHREN ZUR BEHANDLUNG

VON ENTZÜNDUNGEN UND

ZUSAMMENSETZUNGEN DAFÜR

O Viron Therapeutics, Inc.

UWO Research Park, 100 Collip

Circle, Suite 130

London, Ontario N6G 4X8 (CA)

N McFADDEN, D., Grant

1435 Corley Drive South London

Ontario N6G 2K5 (CA)

LUCAS, Alexandra

1435 Corley Drive South London

Ontario N6G 2K5 (CA)

Q PCT/US 19/96004 (En)

R WO 19/96030 () 3.10.1996

I A61K038/57

A 00 904 785

B 98115110.3

C 11.08.1998 Q En

H 31.03.1999 R En

E 15.01.2003

F 11.08.1997 JP 23029497

K Verwendung von Protein C Inhibitor

zur Behandlung disseminierter

intravasaler Gerinnung (DIC)

O JCR PHARMACEUTICALS CO., LTD.

3-19, Kasuga-cho

Ashiya, Hyogo 659-0021 (JP)

N Fujita, Mitsugu

76-1, Nodera, Inami-cho

Kako-gun, Hyogo (JP)

Komurasaki, Yoshikazu

2084-9, Fukui, Miki

Hyogo (JP)

Koh, Keihide

3-5, Nakaharadori 1-chome, Nada-ku

Kobe, Kyogo (JP)

Ishikawa, Hiromichi

14-10, Uosaki-kitamachi 4-chome,

Higashi-Nada-ku

Kobe, Hyogo (JP)

I A 61 K 039/00 Z A 61 K 048/00

A 00 607 309

I A 61 K 039/00 Z A 61 K 009/00

A 00 778 767

I A 61 K 039/00 Z A 61 K 039/395

A 00 999 853

I A 61 K 039/015 Z C 12 N 015/30

A 00 979 284

I A 61 K 039/02 Z C 12 N 015/31

A 00 815 235

I A61K039/12, A 61 K 048/00,

A61P037/04

A 00 930 896

B 97940869.7

C 04.09.1997 Q En

H 28.07.1999 R En

E 02.01.2003

F 06.09.1996 US 25549 P

10.07.1997 US 889930

K VERFAHREN ZUR ERZEUGUNG

DER TOLERANZ EINES

SÄUGETIERPATIENTES GEGEN

VERABREICHUNG VON BEI

GENTHERAPIE GEBRAUCHTEN

VIRALEN VEKTOREN

O THE TRUSTEES OF THE

UNIVERSITY OF PENNSYLVANIA

Center for Technology Transfer,

3700 Market Street, Suite 300

Philadelphia, Pennsylvania

19104-3147 (US)

N CHEN, Youhai

205 Cherry Hill Lane

Broomall, PA 19008 (US)

WILSON, James, M.

1350 N. Avignon Drive

Gladwyne, PA 19035 (US)

Q PCT/US 19/97015 (En)

R WO 19/98009 () 12.3.1998

I A 61 K 039/21 Z C 12 N 015/30

A 00 979 284

I A 61 K 039/245 Z C 12 N 015/38

A 00 628 633

I A 61 K 039/245 Z A 61 K 031/00

A 00 723 440

I A 61 K 039/39 Z A 61 K 038/21

A 01 107 779

I A 61 K 039/395 Z A 61 K 038/00

A 00 646 012

I A61K039/395, C 12 N 001/00,

C12N015/10, C 12 N 015/63,

C12N015/70, C 12 N 015/74

A 00 671 927

B 93921646.1

C 16.09.1993 Q En

H 20.09.1995 R En

E 15.01.2003

F 16.09.1992 US 945515

K MENSCHLICHE, NEUTRALISIERENDE,

MONOKLONALE ANTIKÖRPER

GEGEN DAS RESPIRATORISCHE

SYNZYTIALVIRUS

O THE UNITED STATES

GOVERNMENT, as represented by

THE DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Washington, DC 20231 (US)

THE SCRIPPS RESEARCH INSTITUTE

10666 North Torrey Pines Road

La Jolla, CA 92037 (US)

N BURTON, Dennis, R.

6044 Beaumont Avenue

La Jolla, CA 92037 (US)

BARBAS, Carlos, F., III

7081 Weller Street

San Diego, CA 92123 (US)

CHANOCK, Robert, M.

7001 Longwood Drive

Bethesda, MD 20817 (US)

MURPHY, Brian, R.

5410 Tuscarawas Road

Bethesda, MD 20816 (US)

CROWE, James, E., Jr.

8754 Preston Place

Chevy Chase, MD (US)

Q PCT/US 19/93008 (En)

R WO 19/94006 () 31.3.1994

I A 61 K 039/395 Z C 07 K 016/00

A 00 885 244

I A61K039/395, A 61 K 039/00,

C07K001/00

A 00 999 853

B 98932747.3

C 12.06.1998 Q En

H 17.05.2000 R En

E 02.01.2003

F 13.06.1997 US 874897

K STABILISIERTE

ANTIKÖRPERFORMULIERUNG

O Genentech, Inc.

1 DNA Way

South San Francisco, CA 94080-4990

(US)

N LAM, Xanthe, M.

280 Denslowe Drive

San Francisco, CA 94132 (US)

OESWEIN, James, Q.

P.O. Box 13

Moss Beach, CA 94038 (US)

ONGPIPATTANAKUL, Boonsri

53-55 Charlerm Khet 1 Road

Pomprah, Bangkok 10100 (TH)

SHAHROKH, Zahra

24 Sotelo Avenue

San Francisco, CA 94116 (US)

WANG, Sharon, X.

3187 Greenoak Court

San Mateo, CA 94403 (US)

WEISSBURG, Robert, P.

232B.Presidential Drive

Greenville DE 19807 (US)

WONG, Rita, L.

15 West Summit

Redwood City, CA 94062 (US)

Q PCT/US 19/98012 (En)

R WO 19/98056 () 17.12.1998

I A 61 K 045/00 Z C 12 N 015/30

A 00 979 284

I A61K045/06, A 61 K 031/70

A 00 617 968

B 94302260.8

C 29.03.1994 Q En

H 05.10.1994 R En

E 08.01.2003

F 31.03.1993 US 40729

K HIV Protease Hemmer

in pharmazeutischen

Zusammensetzungen zur

Behandlung von AIDS

O Merck & Co., Inc.

126, East Lincoln Avenue P.O. Box

2000

Rahway New Jersey 07065-0900

(US)

N Vacca, Joseph P.

766 Eisenhauer Drive

Telford, PA 18969 (US)

Holloway, M. Katharine

171 Forest Trail Drive

Lansdale, PA 19446 (US)

Guare, James P.

15.1.2003 +pat+ 1

1 2 ... 28 29 30 31 32 33 34 35 36 37 38 ... 185 186

Comentários a estes Manuais

Sem comentários

BREIL GL10 Manual do Utilizador Página 33

Comentários a estes Manuais